Although drugstores benefited from the pandemic with people getting Covid-19 vaccines, fewer consumers are now visiting stores. Prescription volumes are also declining as people undergo fewer elective procedures. Drugs such as Ozempic and Mounjaro, used for weight loss and diabetes treatment, have not been profitable for the chain. Wentworth told the Journal that Walgreens is losing money on filling these prescriptions.